Venus Remedies inches up on the bourses

05 Dec 2011 Evaluate

Venus Remedies is currently trading at Rs. 170.00, up by 0.10 points or 0.06% from its previous closing of Rs. 169.90 on the BSE.

The scrip opened at Rs. 172.60 and has touched a high and low of Rs. 173.75 and Rs. 169.55 respectively. So far 8,662 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 293.95 on 06-Jan-2011 and a 52 week low of Rs. 165.25 on 30-Nov-2011.

Last one week high and low of the scrip stood at Rs. 175.90 and Rs. 165.25 respectively. The current market cap of the company is Rs. 155.00 crore.

The promoters holding in the company stood at 30.42% while Institutions and Non-Institutions held 16.35% and 53.23% respectively.

Venus Remedies has emerged as a winner of silver certificate of merit in the Economic Times' India Manufacturing Excellence Awards (IMEA), 2011 held in Mumbai. The company has bagged this award for its Baddi unit, based on the assessments conducted at the site and whetted by the jury of Economic Times' IMEA 2011 in partnership with Frost & Sullivan.

This award is recognition and acknowledgement of the company's high standards in terms of its manufacturing practices, quality, regulatory approvals, significant investment on its state-of-the-art R&D centre, well equipped facilities and fine infrastructure. It is an endorsement to continuous its endeavor in building and making Venus Remedies stand amongst the top pharma giants of the industry.

Out of 103 shortlisted companies 35 were conferred with this prestigious award under various categories. This award celebrates success stories and honor entrepreneurs who have dedication, perseverance, foresight and diligence to develop a successful manufacturing organization and sustain continuous learning.

IMEA acknowledges the best facilities in India that have achieved and sustained manufacturing excellence by recognizing the Indian manufacturing capabilities and assessing the global competitiveness.

Besides this, Venus Remedies has recently won the prestigious LACP's (League of American Communications Professionals) Global Communications Competition, the '2011 Spotlight Awards' for its annual report and also bagged 'Patent Award' in Gold category by Pharmexcil (Pharmaceuticals Export Promotion Council).

Venus Remedies Share Price

745.20 -7.70 (-1.02%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×